Articles
Volume 9 Supplement 2
Proceedings of the 8th International Conference on Alzheimer's Disease Drug Discovery
- Reviews
- from 8th International Conference on Alzheimer's Disease Drug Discovery
- New York, NY, USA
- 15-16 October 2007
- Edited by Howard Fillit
- The publication of this supplement was made possible by the generous support of the conference sponsors: Forest Laboratories, Inc.; Bellus Health Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Esai, Inc., Ortho-McNeil Neurologics, Inc.; Sanofi-Aventis US, Inc.; Schering-Plough; Accera, Inc.; Acumen Pharmaceuticals, Inc.; Pfizer Inc.; and Wyeth Research.
|
Review
Small molecule activators of the Trk receptors for neuroprotection Nicholas JG Webster, Michael C Pirrung BMC Neuroscience 2008, 9(Suppl 2):S1 (3 December 2008) |
|
Review
Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, Orly Weinreb, Moussa BH Youdim BMC Neuroscience 2008, 9(Suppl 2):S2 (3 December 2008) |
|
Review
The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review Juan Sanchez-Ramos, Shijie Song, Chuanhai Cao, Gary Arendash BMC Neuroscience 2008, 9(Suppl 2):S3 (3 December 2008) |
|
Review
Selective amyloid-β lowering agents Michael S Wolfe BMC Neuroscience 2008, 9(Suppl 2):S4 (3 December 2008) |
|
Review
Thomas Wisniewski, Martin Sadowski BMC Neuroscience 2008, 9(Suppl 2):S5 (3 December 2008) |
|
Review
Therapeutic potential of resveratrol in Alzheimer's disease Valérie Vingtdeux, Ute Dreses-Werringloer, Haitian Zhao, Peter Davies, Philippe Marambaud BMC Neuroscience 2008, 9(Suppl 2):S6 (3 December 2008) |
|
Review
Heat shock protein 90: translation from cancer to Alzheimer's disease treatment? Wenjie Luo, Anna Rodina, Gabriela Chiosis BMC Neuroscience 2008, 9(Suppl 2):S7 (3 December 2008) |
|
Review
NADPH oxidase as a therapeutic target in Alzheimer's disease Michelle L Block BMC Neuroscience 2008, 9(Suppl 2):S8 (3 December 2008) |
|
Review
Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein Thomas Timm, Alexander Marx, Saravanan Panneerselvam, Eckhard Mandelkow, Eva-Maria Mandelkow BMC Neuroscience 2008, 9(Suppl 2):S9 (3 December 2008) |
|
Review
Alternative splicing of exon 10 in the Jianhua Zhou, Qingming Yu, Tie Zou BMC Neuroscience 2008, 9(Suppl 2):S10 (3 December 2008) |
|
Review
Jun Wang, Roberta Brinton BMC Neuroscience 2008, 9(Suppl 2):S11 (3 December 2008) |
|
Review
The p38α mitogen-activated protein kinase as a central nervous system drug discovery target Aaron S Borders, Lucia de Almeida, Linda J Van Eldik, D Martin Watterson BMC Neuroscience 2008, 9(Suppl 2):S12 (3 December 2008) |
|
Review
Immune defects in Alzheimer's disease: new medications development John R Cashman, Senait Ghirmai, Kenneth J Abel, Milan Fiala BMC Neuroscience 2008, 9(Suppl 2):S13 (3 December 2008) |
|
Review
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase Siew Chai, Holly R Yeatman, Michael W Parker, David B Ascher, Philip E Thompson, Hayley T Mulvey, Anthony L Albiston BMC Neuroscience 2008, 9(Suppl 2):S14 (3 December 2008) |
|
Review
Cognitive-enhancing effects of angiotensin IV Paul R Gard BMC Neuroscience 2008, 9(Suppl 2):S15 (3 December 2008) |
|
Review
Hypometabolism as a therapeutic target in Alzheimer's disease Lauren C Costantini, Linda J Barr, Janet L Vogel, Samuel T Henderson BMC Neuroscience 2008, 9(Suppl 2):S16 (3 December 2008) |
